- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Wayne Burton on the Impact of Workers With Migraine on Employers
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Transcript:
What kind of impact do workers with migraine have on employers? Do employers see a loss of revenue or productivity? How can this be mitigated?
Migraine is extremely important to employers because if you think about migraine headaches, they effect people basically between age 25 and 55—prime age group for workers. Eighteen percent are women, about 6% are men, and it has significant impacts on on-the-job productivity, or so-called presenteeism, as well as direct costs, [like] medical costs [and] pharmacy costs. So, it’s an exceedingly important medical condition for employers.
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
